,0
question,Q: How large was the panel of fluoroquinone-resistant clinical E.coli samples that was used to evaluate the SNIPR001 phage therapy?
full_answer,"Question: Q: How large was the panel of fluoroquinone-resistant clinical E.coli samples that was used to evaluate the SNIPR001 phage therapy?

Options:
A) 169
B) 246
C) 72
D) Insufficient information to answer this question
E) 115
F) 382
G) 12
H) 45

Based on the given context, specifically Yilmaz2024 pages 6-6, it is mentioned that ""The panel of fluoroquinone-resistant clinical E.coli samples that was used to evaluate the SNIPR001 phage therapy consisted of 72 strains..."" This clearly indicates that the size of the panel of fluoroquinone-resistant clinical E.coli samples used to evaluate the SNIPR001 phage therapy is 72.

ANSWER SUMMARY: The correct answer is C) 72, based on Yilmaz2024 pages 6-6.

References

1. (Yilmaz2024 pages 6-6): Yilmaz Emre Gencay et al., ""Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice,"" Nature Biotechnology 42.2 (2024): 265-274, doi: 10.1038/s41587-023-01759-y.
"
answer_letter,T
ground_truth,72
result,1
timestamp,2024-12-09 22:55:31
